134 related articles for article (PubMed ID: 35635891)
1. Corrigendum to "The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)" [Biochem. Pharmacol. 194 (2021) 114840].
Sutter ML; Console L; Fahner AF; Samodelov SL; Gai Z; Ciarimboli G; Indiveri C; Kullak-Ublick GA; Visentin M
Biochem Pharmacol; 2022 Jul; 201():115100. PubMed ID: 35635891
[No Abstract] [Full Text] [Related]
2. The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2).
Sutter ML; Console L; Fahner AF; Samodelov SL; Gai Z; Ciarimboli G; Indiveri C; Kullak-Ublick GA; Visentin M
Biochem Pharmacol; 2021 Dec; 194():114840. PubMed ID: 34774844
[TBL] [Abstract][Full Text] [Related]
3. Organic cation transporter 2 (SLC22A2), a low-affinity and high-capacity choline transporter, is preferentially enriched on synaptic vesicles in cholinergic neurons.
Nakata T; Matsui T; Kobayashi K; Kobayashi Y; Anzai N
Neuroscience; 2013 Nov; 252():212-21. PubMed ID: 23958595
[TBL] [Abstract][Full Text] [Related]
4. Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2).
Hörmann S; Gai Z; Kullak-Ublick GA; Visentin M
J Pharmacol Exp Ther; 2020 Jan; 372(1):46-53. PubMed ID: 31624079
[TBL] [Abstract][Full Text] [Related]
5. Relevance of CARC and CRAC Cholesterol-Recognition Motifs in the Nicotinic Acetylcholine Receptor and Other Membrane-Bound Receptors.
Di Scala C; Baier CJ; Evans LS; Williamson PTF; Fantini J; Barrantes FJ
Curr Top Membr; 2017; 80():3-23. PubMed ID: 28863821
[TBL] [Abstract][Full Text] [Related]
6. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation.
Aoki M; Terada T; Kajiwara M; Ogasawara K; Ikai I; Ogawa O; Katsura T; Inui K
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F165-70. PubMed ID: 18508876
[TBL] [Abstract][Full Text] [Related]
7. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.
Fujita T; Urban TJ; Leabman MK; Fujita K; Giacomini KM
J Pharm Sci; 2006 Jan; 95(1):25-36. PubMed ID: 16307453
[TBL] [Abstract][Full Text] [Related]
8. The Role of NF-kB in the Downregulation of Organic Cation Transporter 2 Expression and Renal Cation Secretion in Kidney Disease.
Han C; Zheng J; Wang F; Lu Q; Chen Q; Hu A; Visentin M; Kullak-Ublick GA; Gai Z; Chu L
Front Med (Lausanne); 2021; 8():800421. PubMed ID: 35059420
[TBL] [Abstract][Full Text] [Related]
9. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Cisplatin with the human organic cation transporter 2.
Filipski KK; Loos WJ; Verweij J; Sparreboom A
Clin Cancer Res; 2008 Jun; 14(12):3875-80. PubMed ID: 18559608
[TBL] [Abstract][Full Text] [Related]
11. Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors.
Visentin M; Torozi A; Gai Z; Häusler S; Li C; Hiller C; Schraml PH; Moch H; Kullak-Ublick GA
Drug Metab Dispos; 2018 Aug; 46(8):1129-1136. PubMed ID: 29794161
[TBL] [Abstract][Full Text] [Related]
12. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).
Zolk O; Solbach TF; König J; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):337-48. PubMed ID: 19002438
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
[TBL] [Abstract][Full Text] [Related]
15. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
Filipski KK; Mathijssen RH; Mikkelsen TS; Schinkel AH; Sparreboom A
Clin Pharmacol Ther; 2009 Oct; 86(4):396-402. PubMed ID: 19625999
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
Zolk O; Solbach TF; König J; Fromm MF
Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
[TBL] [Abstract][Full Text] [Related]
17. Substrate-Dependent
Lefèvre CR; Le Vée M; Gaubert S; Jouan E; Bruyere A; Moreau C; Fardel O
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884730
[TBL] [Abstract][Full Text] [Related]
18. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
Nies AT; Herrmann E; Brom M; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
[TBL] [Abstract][Full Text] [Related]
19. The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26.
Koehler MR; Wissinger B; Gorboulev V; Koepsell H; Schmid M
Cytogenet Cell Genet; 1997; 79(3-4):198-200. PubMed ID: 9605850
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition.
Song IS; Lee DY; Shin MH; Kim H; Ahn YG; Park I; Kim KH; Kind T; Shin JG; Fiehn O; Liu KH
PLoS One; 2012; 7(5):e36637. PubMed ID: 22590580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
